Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
Mariam AnjumInger AriansenVidar HjellvikRandi SelmerLars J KjerpesethEva SkovlundMarius MyrstadHanne EllekjærIngrid E ChristophersenArnljot TveitTrygve BergePublished in: European heart journal (2023)
In AF patients at intermediate risk of stroke, OAC use was associated with overall favourable clinical outcomes. Non-anticoagulated AF patients had higher risk of ischaemic stroke compared to the general population without AF with the same risk profile.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- direct oral anticoagulants
- heart failure
- end stage renal disease
- percutaneous coronary intervention
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- patient reported outcomes
- left ventricular
- venous thromboembolism
- patient reported
- subarachnoid hemorrhage